Evidence map›Paper›PMID 28862970›Full record

ArticleJournal of the American Heart Association2017

Clinical Outcomes of Deferred Lesions With Angiographically Insignificant Stenosis But Low Fractional Flow Reserve.

Joo Myung Lee, Bon-Kwon Koo, Eun-Seok Shin, Chang-Wook Nam, Joon-Hyung Doh, Xinyang Hu, Fei Ye, Shaoliang Chen, Junqing Yang, Jiyan Chen and 10 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Heart Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01621438 (Influence of Total Atherosclerotic Burden Assessed by 3-vessel Fractional Flow Reserve), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01621438 unknown statusnot on this map

Influence of Total Atherosclerotic Burden Assessed by 3-vessel Fractional Flow Reserve (FFR) on the Clinical Outcomes of the Patients With Multi-vessel Disease

TypeobservationalSponsorSeoul National University HospitalRan2012 to 2018Enrolled1,136ConditionsMultivessel Coronary Artery Disease
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Joo Myung LeeDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Bon-Kwon KooDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea bkkoo@snu.ac.kr wang_jian_an@tom.com.
Eun-Seok ShinDepartment of Cardiology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
Chang-Wook NamDepartment of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.
Joon-Hyung DohDepartment of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.
Xinyang HuDepartment of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China.
Fei YeDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Shaoliang ChenDepartment of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Junqing YangGuangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Jiyan ChenGuangdong Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Nobuhiro TanakaDepartment of Cardiology, Tokyo Medical University, Tokyo, Japan.
Hiroyoshi YokoiKokura Memorial Hospital, Kitakyuku, Japan.
Hitoshi MatsuoDepartment of Cardiology, Gifu Heart Center, Gifu, Japan.
Hiroaki TakashimaDepartment of Cardiology, Aichi Medical University, Nagakute, Japan.
Yasutsugu ShionoWakayama Medical University, Wakayama, Japan.
Doyeon HwangDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Jonghanne ParkDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Kyung-Jin KimDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
Takashi AkasakaWakayama Medical University, Wakayama, Japan.
Jianan WangDepartment of Cardiology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Zhejiang, China bkkoo@snu.ac.kr wang_jian_an@tom.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundData are limited regarding outcomes of deferred lesions in patients with angiographically insignificant stenosis but low fractional flow reserve (FFR). We investigated the natural history of angiographically insignificant stenosis with low FFR among patients who underwent routine 3-vessel FFR measurement. METHODS AND

resultsFrom December 2011 to March 2014, 1136 patients with 3298 vessels underwent routine 3-vessel FFR measurement (3V FFR-FRIENDS study, ClinicalTrials.gov identifier NCT01621438), and this study analyzed the 2-year clinical outcomes of 1024 patients with 2124 lesions with angiographically insignificant stenosis (percentage of diameter stenosis <50%), in which revascularization was deferred. All lesions were classified according to FFR values, using a cutoff of 0.80 (high FFR >0.80 versus low FFR ≤0.80). The primary end point was outcome of major adverse cardiovascular events (a composite of cardiac death, myocardial infarction, and ischemia-driven revascularization) at 2 years. Mean angiographic percentage of diameter stenosis and FFR of total lesions were 32.5±10.3% and 0.91±0.08%, respectively. Among the total lesions with angiographically insignificant stenosis, 8.7% showed low FFR (185 lesions). The incidence of lesions with low FFR was 2.5%, 3.8%, 9.0%, and 15.1% in categories of percentage of diameter stenosis <20%, 20% to 30%, 30% to 40%, and 40% to 50%, respectively. At 2-year follow-up, the low-FFR group showed a significantly higher risk of major adverse cardiovascular events compared with the high FFR group (3.3% versus 1.2%, hazard ratio: 3.371; 95% CI, 1.346-8.442;

conclusionsIn deferred angiographically insignificant stenosis, lesions with low FFR showed significantly higher event rates than those with high FFR. FFR was an independent predictor of future major adverse cardiovascular events in lesions with angiographically insignificant stenosis. CLINICAL

trial registrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT01621438.

Indexed as

Cardiac CatheterizationCoronary AngiographyFractional Flow Reserve, MyocardialAgedAsiaCoronary StenosisCoronary VesselsFemaleHumansKaplan-Meier EstimateLinear ModelsMaleMiddle AgedMultivariate AnalysisMyocardial Perfusion ImagingPositron-Emission Tomographycoronary artery diseasediscordancefractional flow reserveprognosisreverse mismatchstents

Identifiers

PMID28862970
PMCPMC5586447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.